ARO-ENaC

As Arrowhead falters, lungs remain a tough target for RNA drugs
BioPharma Dive
Wed, 07/7/21 - 11:00 am
RNA
Arrowhead
ARO-ENaC
cystic fibrosis
Arrowhead Pharmaceuticals files for regulatory clearance to begin phase 1/2a study of ARO-ENaC for treatment of cystic fibrosis
Pharmaceutical Business Review
Mon, 04/13/20 - 10:50 am
Arrowhead Pharmaceuticals
clinical trials
cystic fibrosis
ARO-ENaC
RNAi